Brief: Genflow Biosciences Says Slab Clinical Trial Meets Primary Endpoint
08/09/2026 07:50
BRIEF-Genflow Biosciences Says Slab Clinical Trial Meets Primary Endpoint Sept 8 (Reuters) - Genflow Biosciences PLC GENF.L:
GENFLOW BIOSCIENCES - PRIMARY ENDPOINT IN SLAB CLINICAL TRIAL MET
GENFLOW BIOSCIENCES - SLAB CLINICAL TRIAL MEETS PRIMARY ENDPOINT
GENFLOW BIOSCIENCES - DETAILED SLAB TRIAL RESULTS TO BE PRESENTED AT ANIMAL LONGEVITY SUMMIT OCTOBER 2026
Source text: ID:nRSH7471Ta
Further company coverage: GENF.L
((Reuters.Briefs@thomsonreuters.com;))